PRESS RELEASES

9th July 2020

Three Local Cos Working on Antibody Drugs for COVID

The Economic Times, 9 July 2020:

Bharat Serums and Vaccines has begun preclinical work for developing a possible treatment for Covid-19 using antibodies from horses — a pathway that premier medical research institute Indian Council of Medical Research is looking to develop. The equine antisera pathway with which the Mumbai-based company is working is already used in treatments against snake bites, rabies, and diphtheria.



Read more: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/mumbai-company-working-on-covid-treatment-using-antibodies-from-horses/articleshow/76865180.cms

ban1


About BSV

BSV has been a pioneer in the development of blood components and therapeutic antibody products for infectious and non-infectious diseases. For over four decades, BSVL has focused on utilizing its scientific resources to develop several biological, biotechnology and pharmaceutical products to treat various types of diseases, contributing to preserve, protect and enhance the quality of life. We aim to be a leading biopharmaceutical company driven by people & science to set benchmarks in patient outcomes in Women’s Health, Critical Care & Emergency Medicine.



For more information, please contact:

Irawati Gowariker, BSV, Irawati.gowariker@bsvgroup.com